Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans

P Duggal1, P An, T H Beaty

  • 1Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Genes and Immunity
|May 23, 2003
PubMed

Insights

The CXCR6-3K genetic variant is common in African Americans and associated with longer survival after Pneumocystis pneumonia (PCP) in HIV-infected individuals. This CXCR6 genotype may influence late-stage HIV progression.

Area of Science:

  • Immunology
  • Genetics
  • Virology

Background:

  • CXCR6 is a key coreceptor in SIV infection.
  • A specific polymorphism (CXCR6-E3K) alters the N-terminus of the CXCR6 coreceptor.
  • Pneumocystis pneumonia (PCP) is a common opportunistic infection in HIV/AIDS.

Purpose of the Study:

  • To investigate the association between CXCR6 genotype and PCP progression and survival in HIV-infected individuals.
  • To determine the role of the CXCR6-E3K polymorphism in disease progression and mortality.

Main Methods:

  • Clinical assessment and genotyping of 805 African-American injection drug users in Baltimore, MD.
  • Analysis of the CXCR6-E3K polymorphism and its correlation with time to AIDS, PCP, and survival post-PCP.
  • Comparison of allele frequencies between African Americans and European Americans.

Main Results:

  • The CXCR6-3K allele frequency was high (44%) in African Americans and rare (<1%) in European Americans.
  • No significant difference in time to AIDS or PCP across CXCR6 genotypes.
  • Median survival time from PCP to death was significantly longer for the CXCR6-K/K genotype (3.1 years) compared to CXCR6-3E/E and CXCR6-3E/K genotypes (1.5 years).
  • Individuals with CXCR6-3E alleles were 5.6 times more likely to die from PCP-mediated AIDS-related causes.

Conclusions:

  • CXCR6 genotype is associated with survival duration after PCP diagnosis in African-American HIV-infected individuals.
  • The CXCR6-3K allele confers a survival advantage post-PCP.
  • CXCR6 may influence late-stage HIV-1 infection progression and mortality.

Related Concept Videos

Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...